Los Angeles Capital Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Los Angeles Capital Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-18,877	Closed	-$2.13M	–	1406
2017 Q3	$2.13M	Sell	18,877 -32,543	-63%	-$3.54M	0.01%	605
2017 Q2	$5.76M	Sell	51,420 -4,379	-8%	-$495K	0.04%	411
2017 Q1	$6.51M	Buy	55,799 +1,321	+2%	+$146K	0.05%	366
2016 Q4	$5.74M	Buy	54,478 +3,678	+7%	+$385K	0.04%	384
2016 Q3	$5.61M	Hold	50,800	–	–	0.05%	397
2016 Q2	$7.4M	Buy	+50,800	New	+$7.2M	0.06%	319
2016 Q1	–	Sell	-2,500	Closed	-$386K	–	1205
2015 Q4	$386K	Buy	+2,500	New	+$365K	﹤0.01%	921

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

Los Angeles Capital Management's TARO Position: Q4 2017 in Review

Los Angeles Capital Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2017, closing a stake of 18,877 shares — an estimated $2.13M sold.

Los Angeles Capital Management first reported a position in TARO in Q4 2015 and held it in 7 quarters. The position peaked at $7.4M in Q2 2016. 127 funds tracked by Wall St. Rank hold TARO as of Q4 2017.

Los Angeles Capital Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2017 after selling out during the quarter.
Los Angeles Capital Management sold 18,877 Taro Pharmaceutical Industries Ltd. shares in Q4 2017, an estimated $2.13M.
Los Angeles Capital Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and held it in 7 quarters.
Los Angeles Capital Management's Taro Pharmaceutical Industries Ltd. position peaked at $7.4M in Q2 2016.
127 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2017.

Based on Los Angeles Capital Management's 13F filing for Q4 2017, filed 5 Feb 2018.